Here’s what you should know
1. Envision lost 28.3 percent of its value during the quarter.
2. The Fool attributes the loss to several factors. Envision revised its full-year guidance downward to reflect decreased emergency medicine volume, and Envision also agreed to sell its American Medical Response business to KKR for $2.4 billion, decreasing total portfolio holdings in the space.
3. The Fool reports investors are still bullish on the late-2016 merger of Envision and AmSurg, but admits, “the company is going through a rough patch that could continue to challenge the stock in the months ahead.”
More articles on improving performance:
Sentara closing medical center, ASC in Kitty Hawk — 6 key notes
The top 10 US cities for disabled people
After CHIP funding lapses, 9M children at risk of losing coverage — 4 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
